BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20021940)

  • 1. [Gene profiling after knocking-down the expression of NS gene in prostate cancer PC-3 cells].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):561-5. PubMed ID: 20021940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of nucleostemin causes G1 cell cycle arrest via a p53-independent pathway in prostate cancer PC-3 cells.
    Liu R; Zhang Z; Xu Y
    Urol Int; 2010; 85(2):221-7. PubMed ID: 20664182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells.
    Liu RL; Zhang ZH; Zhao WM; Wang M; Qi SY; Li J; Zhang Y; Li SZ; Xu Y
    Chin Med J (Engl); 2008 Feb; 121(4):299-304. PubMed ID: 18304460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene profiling after knocking-down expression of nucleostemin in Hela cells using oligonucleotide DNA microarray.
    Liu SJ; Zhang ZH; Zhang DQ; Sui XM; Liu YJ; Cai ZW; Yuan XY; Sun LQ; Hu GF; Liu RL
    J Exp Clin Cancer Res; 2006 Dec; 25(4):575-83. PubMed ID: 17310849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
    Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
    Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.
    Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A; Shi R; Glass J; Mathis JM; Williams BJ; Meyers S
    J Cell Physiol; 2010 Nov; 225(3):875-87. PubMed ID: 20607802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
    Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxazosin induces apoptosis in LNCaP prostate cancer cell line through DNA binding and DNA-dependent protein kinase down-regulation.
    Arencibia JM; Del Rio M; Bonnin A; Lopes R; Lemoine NR; López-Barahona M
    Int J Oncol; 2005 Dec; 27(6):1617-23. PubMed ID: 16273218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells.
    Guzey M; Luo J; Getzenberg RH
    J Cell Biochem; 2004 Oct; 93(2):271-85. PubMed ID: 15368355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray].
    Chen G; Geng J; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1489-92. PubMed ID: 16061029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of HL-60 cells following knockdown of nucleostemin using DNA microarrays.
    Sun X; Jia Y; Wei Y; Liu S; Yue B
    Oncol Rep; 2014 Aug; 32(2):739-47. PubMed ID: 24912530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
    Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Silencing nucleostemin expression reduces the proliferation of PC-3 cells].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2009 Jul; 15(7):593-8. PubMed ID: 19694370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.